Amber Laboratories

Amber Laboratories is a pharmaceutical company headquartered in Mumbai, India, specializing in the development and manufacture of advanced pharmaceutical pellets, granules, and finished dosage forms. Established in 1995, the company has built a strong reputation for its expertise in modified-release drug delivery systems, including sustained-release, delayed-release, and enteric-coated formulations. Amber Laboratories operates state-of-the-art manufacturing facilities that comply with international regulatory standards, providing high-quality generic products across therapeutic areas such as gastroenterology, cardiology, neurology, and anti-infectives. The company serves as a key partner for global pharmaceutical firms through contract manufacturing (CMO) and the supply of active pharmaceutical ingredients (APIs). Their extensive product portfolio includes widely used medications such as omeprazole, itraconazole, and venlafaxine, catering to both domestic and international markets.